Roche Collaborates with Genesis Therapeutics for AI-Driven Drug Discovery

 Roche Collaborates with Genesis Therapeutics for AI-Driven Drug Discovery

Roche Collaborates with Genesis Therapeutics for AI-Driven Drug Discovery

Shots:

  • Genesis to receive an up front and is eligible to receive pre/ clinical and regulatory milestones along with royalties on sales of approved drugs emerges from the collaboration
  • The collaboration leverages Genesis’ graph machine learning and drug discovery expertise to identify drug candidates for therapeutic targets across multiple disease areas
  • Genesis has developed Dynamic PotentialNet and other neural network algorithms, examining drug-target complexes as flexible, spatial graphs, with the advantage of superior potency and selectivity prediction uniquely toward novel, previously undruggable targets and characterized therapeutic targets

Click here ­to­ read full press release/ article | Ref: BusinessWire | Image: BusinessWire

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post